Mirae Asset Global Investments
SWTX

Mirae Asset Global Investments’s SpringWorks Therapeutics SWTX Stock Holding History

Mirae Asset Global Investments’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,530
Closed -$120K – 1643
2025
Q1 		$120K Buy
2,530
+51
+2% +$2.35K ﹤0.01% 1100
2024
Q4 		$90.1K Sell
2,479
-207
-8% -$7.23K ﹤0.01% 1165
2024
Q3 		$86.7K Buy
2,686
+474
+21% +$17.7K ﹤0.01% 1213
2024
Q2 		$83K Sell
2,212
-21,219
-91% -$893K ﹤0.01% 1165
2024
Q1 		$770K Sell
23,431
-13,389
-36% -$619K ﹤0.01% 1677
2023
Q4 		$1.34M Buy
36,820
+3,187
+9% +$83.2K ﹤0.01% 1462
2023
Q3 		$778K Sell
33,633
-2,461
-7% -$67.3K ﹤0.01% 1664
2023
Q2 		$939K Buy
36,094
+10,447
+41% +$275K ﹤0.01% 1607
2023
Q1 		$660K Buy
25,647
+9,071
+55% +$265K ﹤0.01% 1790
2022
Q4 		$431K Buy
16,576
+829
+5% +$20.4K ﹤0.01% 1968
2022
Q3 		$449K Buy
15,747
+5,720
+57% +$164K ﹤0.01% 1930
2022
Q2 		$247K Buy
+10,027
New +$367K ﹤0.01% 2075

Other funds holding SWTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Mirae Asset Global Investments's SWTX Position: Q2 2025 in Review

Mirae Asset Global Investments sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 2,530 shares — an estimated $120K sold.

Mirae Asset Global Investments first reported a position in SWTX in Q2 2022 and held it in 12 quarters. The position peaked at $1.34M in Q4 2023. 222 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

  • Mirae Asset Global Investments reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 2,530 SpringWorks Therapeutics shares in Q2 2025, an estimated $120K.
  • Mirae Asset Global Investments first reported a position in SpringWorks Therapeutics in Q2 2022 and held it in 12 quarters.
  • Mirae Asset Global Investments's SpringWorks Therapeutics position peaked at $1.34M in Q4 2023.
  • 222 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Mirae Asset Global Investments's 13F filing for Q2 2025, filed 21 Jul 2025.